These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 559229)

  • 1. Combination therapy for osteoporosis.
    Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
    Metabolism; 1977 Jul; 26(7):787-92. PubMed ID: 559229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of osteoporosis with calcitonin, with and without growth hormone.
    Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
    Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin.
    Cantatore FP; Carrozzo M; Magli DM; D'Amore M; Pipitone V
    Clin Rheumatol; 1987 Dec; 6(4):504-9. PubMed ID: 3502402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
    Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
    Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcitonin and vitamin D in osteoporosis.
    Palmieri GM; Pitcock JA; Brown P; Karas JG; Roen LJ
    Calcif Tissue Int; 1989 Sep; 45(3):137-41. PubMed ID: 2505903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
    Erlacher L; Kettenbach J; Kiener H; Graninger W; Kainberger F; Pietschmann P
    Wien Klin Wochenschr; 1997 Apr; 109(8):270-4. PubMed ID: 9163888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth hormone in osteoporosis.
    Aloia JF; Zanzi I; Ellis K; Jowsey J; Roginsky M; Wallach S; Cohn SH
    J Clin Endocrinol Metab; 1976 Nov; 43(5):992-9. PubMed ID: 993324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.
    Reginster JY; Denis D; Albert A; Deroisy R; Lecart MP; Fontaine MA; Lambelin P; Franchimont P
    Lancet; 1987 Dec; 2(8574):1481-3. PubMed ID: 2892047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosis.
    Jackson EC; Strife CF; Tsang RC; Marder HK
    Am J Dis Child; 1988 Nov; 142(11):1237-9. PubMed ID: 3177335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis.
    Gennari C
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():61-5. PubMed ID: 2667872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis.
    Robin JC; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):491-8. PubMed ID: 7079575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of osteogenesis imperfecta tarda in adults with salmon calcitonin and calcium.
    Zanzi I; Wallach S; Ellis KJ; Aloia JF; Atkins HL; Cohn SH
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):189-97. PubMed ID: 813957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent acquisitions in therapy of osteoporosis of various etiologies with calcitonin].
    Vigo PL; Di Ciano L; Girardello R; Reschini E; Polli E
    Recenti Prog Med; 1977 Jun; 62(6):649-70. PubMed ID: 578332
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sequential calcitriol-calcitonin in the therapy of osteoporosis].
    Passeri M; Palummeri E; Barbagallo M; Butturini L; Pedrazzoni M; Davoli L; Pioli G; Benassi L; Girasole G; Ciotti G
    Minerva Endocrinol; 1989; 14(1):57-62. PubMed ID: 2659953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Densitometric analysis in in vivo evaluation of synthetic salmon calcitonin activity.
    Gnudi S; Mongiorgi R; Moroni A; Bertocchi G
    J Clin Pharm Ther; 1988 Apr; 13(2):125-30. PubMed ID: 3392126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy for osteoporosis with estrogen, fluoride, and calcium.
    Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
    J Am Geriatr Soc; 1982 Jan; 30(1):13-7. PubMed ID: 7056975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.